Abnormal Earnings Calculator
A company can post a healthy profit and still leave its shareholders worse off. If the profit does not cover the return investors required for the risk they took, the business earned money on paper while destroying value in economic terms. Abnormal earnings are the tool that separates those two stories: they measure what is left after the equity capital behind the profit has been charged its fair rent.
The Abnormal Earnings Calculator below takes net income, equity capital (book value), and the cost of equity, and returns the abnormal earnings figure, also called residual income. It also shows the required earnings your capital had to produce, the return on equity, and the spread between the two. Add the optional growth rate and it goes one step further, turning this year’s abnormal earnings into an implied equity value with the single-stage residual income model.
Do not confuse this with an earnings surprise or with abnormal return. An earnings surprise compares reported profit with analyst forecasts, and abnormal return compares a stock’s actual return with the return a benchmark or asset-pricing model predicted. This page is about something different: earnings measured against the cost of the equity that produced them. If the return side is what you need, that is the abnormal return concept, covered on its own page. Here, everything runs through the income statement and the balance sheet.
Quick Answer
Key takeaways
- Abnormal earnings = net income minus (equity capital x cost of equity). Profit only counts as value creation after the equity charge is paid.
- The ROE spread says the same thing in percentage form: ROE minus the cost of equity. A 12% ROE against a 10% cost of equity is a +2 point spread and $20,000 of residual income on $1,000,000 of equity.
- The residual income model values equity as book value plus the present value of future abnormal earnings. Book value is the floor; the premium comes only from earnings above the charge.
- The growth rate in the valuation step must stay below the cost of equity, or the formula implies infinite value and the tool refuses to print it.
The formula, step by step
Three short steps take you from the financial statements to the verdict, and one optional step turns the verdict into a valuation.
Charge the equity. Multiply equity capital by the cost of equity. On $1,000,000 at 10%, shareholders require $100,000 of earnings just to break even economically. This is the equity charge, sometimes called required earnings.
Subtract the charge from net income. $120,000 minus $100,000 leaves $20,000. That remainder is the abnormal earnings: the profit that belongs to value creation rather than to compensating capital.
Read the spread. ROE is net income divided by equity, here 12.00%. Subtract the 10% cost of equity and the +2.00 point spread confirms the dollar answer: positive spread, positive residual income.
Optional: capitalize the stream. Grow abnormal earnings one year at the growth rate, then divide by (cost of equity minus growth). Add book value and you have the single-stage residual income value of equity.
Where does the cost of equity come from? Most analysts estimate it with CAPM, the model the CFA Institute sets out in its residual income valuation reading as the standard companion to this approach. You can build that estimate with the CAPM expected return calculator, and if the beta input is the piece you are unsure of, the beta calculator works that input out from returns data.
Worked example, checked against this exact tool
These are the pre-filled defaults, run through the calculator’s own code line by line:
| Figure | Value |
|---|---|
| Net income | $120,000.00 |
| Equity capital (book value) | $1,000,000.00 |
| Equity charge ($1,000,000 x 10%) | $100,000.00 |
| Abnormal earnings ($120,000 minus $100,000) | $20,000.00 |
| ROE ($120,000 divided by $1,000,000) | 12.00% |
| Spread (12.00% minus 10%) | +2.00 pp |
| Next-year AE ($20,000 x 1.03) | $20,600.00 |
| Implied equity value ($1,000,000 + $20,600 / 7%) | $1,294,285.71 |
Read the bars as a waterfall in words: of every $120,000 the company earned, $100,000 was already spoken for by the cost of the capital that produced it. Only the last $20,000 slice is genuinely abnormal, and it is that slice, grown and discounted, that lifts the implied value $294,285.71 above book value.
Why abnormal earnings matter
Net income on its own flatters capital-heavy businesses. A firm can double its profit simply by doubling the equity invested in it, without getting any better at what it does. Abnormal earnings remove that illusion, because the equity charge grows with the capital base. Profit that rises only because capital rose leaves residual income flat, and profit that rises slower than capital actually destroys it.
That is why the measure sits at the center of residual income valuation, the approach formalized in Ohlson’s work and summarized in the residual income valuation overview: a company is worth its book value plus the discounted stream of its future abnormal earnings. A firm that will earn exactly its cost of equity forever is worth exactly its book value, no more. Persistent positive abnormal earnings are the accounting signature of a durable advantage: a brand, a patent portfolio, a cost position, or a network that keeps returns above the charge year after year. Persistent negative abnormal earnings say the opposite, that capital would earn more elsewhere.
One honest limit: the model is only as good as the accounting underneath it. Book value is distorted by share buybacks, write-downs, and aggressive depreciation, and the cost of equity is an estimate, not a measurement. A one-point change in the cost of equity moves the worked example’s implied value by well over $100,000. Treat the output as a disciplined sanity check on a valuation story, and cross-check any per-share conclusion against market-based measures such as the returns history in the S&P 500 returns calculator before acting on it.
Single-stage versus multi-stage: what this tool does and does not do
The valuation step here is single-stage: it assumes abnormal earnings grow at one constant rate forever. That is simple and transparent, and for a mature firm with a stable spread it is a reasonable first pass. It is also generous, because real advantages erode. A multi-stage model projects a high-growth phase for abnormal earnings that fades toward zero as competition arrives, which suits younger firms and produces lower, often more believable values. This tool deliberately implements the single-stage version only, with the growth guard switched on: if you enter a growth rate at or above the cost of equity, the valuation is skipped rather than printed, because the underlying series diverges and the honest answer is that the inputs, not the company, are wrong.
What competing calculators miss
We reviewed the top-ranking abnormal earnings and residual income pages before rebuilding this one. The tools agree on the subtraction. They part company on everything after it.
Winning move 1: the valuation is actually computed. The leading competing calculator takes the same three inputs and stops at the abnormal earnings dollar figure. Longer guide-style pages describe the residual income model in prose, with a worked example, and then leave you to do the capitalization yourself. This page closes the loop: enter a growth rate and the single-stage implied equity value appears next to the abnormal earnings, $1,294,285.71 on the standard example, computed by the tool rather than asserted in text.
Winning move 2: the spread, not just the dollars. A $20,000 residual means little until you know the capital base behind it. The ROE and the spread over the cost of equity are printed with the result, so a 12% ROE against a 10% charge reads instantly as a +2 point value-creating spread. Competing tools make you divide by equity yourself to learn whether the dollar figure is impressive or trivial.
Winning move 3: a guard against the divergent case. Set growth equal to or above the cost of equity and the textbook formula returns infinity. Most tools either ignore the growth input entirely or would happily divide by zero or a negative number. This one detects the case and tells you plainly that the valuation is skipped and why.
Winning move 4: the name collision is confronted. Search results for this topic routinely mix residual income with earnings surprises and abnormal returns, three different ideas sharing vocabulary. The note above separates them in one paragraph, so a student revising for an exam does not walk away with the wrong definition.
Frequently asked questions
Abnormal earnings are the earnings left after charging the equity capital for its required return: net income minus (equity capital x cost of equity). They are also called residual income or economic profit. Positive abnormal earnings mean the firm earned more than shareholders required for the risk taken; negative means it fell short, even if the reported profit was positive.
AE = net income minus (equity x cost of equity). With net income of $120,000, equity of $1,000,000, and a 10% cost of equity, the equity charge is $100,000 and abnormal earnings are $120,000 minus $100,000 = $20,000. Equivalently, multiply the ROE spread by equity: (12% minus 10%) x $1,000,000 = $20,000.
It means the firm earned less than its shareholders require, so it destroyed economic value during the period. A company can report a positive net income and still have negative abnormal earnings: $80,000 of profit on $1,000,000 of equity at a 10% cost of equity leaves abnormal earnings of minus $20,000, because the first $100,000 was owed to the capital itself.
With the single-stage residual income model: V = book value + AE x (1 + g) divided by (r minus g). In the worked example that is $1,000,000 + $20,600 divided by 7%, which gives $1,294,285.71. The model says equity is worth book value plus the capitalized value of the abnormal earnings stream.
Because the valuation sums an infinite stream of growing abnormal earnings. If growth equals or exceeds the discount rate, each future term is as large as or larger than the one before after discounting, the series never converges, and the formula implies infinite value. Economically, no firm outgrows its required return forever, so the tool refuses that input combination.
For established firms, estimates typically land between 8% and 12%, usually built with CAPM: the risk-free rate plus beta times the market risk premium. Riskier, smaller, or more leveraged companies sit above that range. The choice matters: on the worked example, moving the cost of equity from 10% to 11% cuts abnormal earnings from $20,000 to $10,000 and pulls the implied value down sharply.
No. Abnormal earnings (this page) compare net income with the cost of equity capital and feed valuation. Abnormal return compares a security’s actual return with the return predicted by a benchmark or CAPM, and is used in event studies and performance measurement. An earnings surprise compares reported EPS with analyst consensus. Three different subtractions, three different jobs.
Add This Calculator to Your Website
References
- CFA Institute, “Residual Income Valuation” refresher reading – the professional treatment of residual income, the equity charge, and single-stage and multistage residual income models used in equity valuation. CFA Institute: Residual Income Valuation. Accessed October 2026.
- Residual income valuation, reference overview – the Ohlson framework, the clean surplus relation, and the derivation of equity value as book value plus discounted future residual income. Residual Income Valuation: Overview and Derivation. Accessed October 2026.
- Residual income, reference overview – the definition of residual income as income in excess of the cost of capital, in both its personal finance and corporate (equity charge) forms. Residual Income: Definition and the Equity Charge Form. Accessed October 2026.
- Cost of equity, reference overview – how the cost of equity is defined and estimated, including the CAPM and dividend growth approaches behind the required return used in the equity charge. Cost of Equity: Definition and Estimation. Accessed October 2026.
- NYU Stern School of Business, Aswath Damodaran, “Estimating Risk Parameters” (Investment Valuation lecture notes) – how beta and the cost of equity are estimated in practice for valuation models. Damodaran (NYU Stern): Estimating Beta and Cost of Equity. Accessed October 2026.